Mercy Ewere
Family · Houston, TXNPI 1467822692
Payments from drug & device makers
What this record shows
Almost everything reported here is food and beverage — 99.9% of the total across 97 separate payments, which is the pattern of a clinician who attends manufacturer presentations rather than one with a consulting arrangement. 32 manufacturers reported payments, led by Viiv Healthcare Company at 27.0% of the total. 2025 is the largest year on record at $2,736, 2.6 times the $1,034 reported in 2021. Among family clinicians in TX with any reported payments, this total sits in the top 5% — high for the specialty, which is a reason to read the composition above rather than the number alone.
Across 97 payments — averaging $100.14 each. Meals, travel, consulting and speaking fees, gifts and royalties reported by drug and device makers.
- Viiv Healthcare Company$3K
- Gilead$2K
- Janssen Products, LP$671
- AbbVie$480
- Theratechnologies Inc.$395
- Sanofi$353
- plus $3K from 26 others
What the payments were for
- Travel & lodging$110%
- Food & beverage$9,703100%
Most of this is food and beverage — typically meals provided during product presentations at a clinic or hospital. Nationally that is the single largest category of reported payments by count.
General payments by program year
Who reported the general payments
Companies are grouped under their corporate parent — a single manufacturer often files under several CMS reporting entities. Research and ownership payments are counted separately and are not in this table.
| Company | Payments | Total |
|---|---|---|
| Viiv Healthcare Company | 25 | $2,618 |
| Gilead | 18 | $1,711 |
| Janssen Products, LP | 6 | $671 |
| AbbVie | 5 | $480 |
| Theratechnologies Inc. | 4 | $395 |
| Sanofi | 3 | $353 |
| AstraZeneca(2 entities) | 3 | $294 |
| Inspire Medical Systems, Inc. | 2 | $251 |
| Abbott | 2 | $242 |
| Lilly USA, LLC | 3 | $229 |
| Corcept Therapeutics | 2 | $206 |
| Teva Pharmaceuticals USA, Inc. | 2 | $206 |
| Pfizer | 2 | $202 |
| Madrigal Pharmaceuticals | 1 | $149 |
| Phathom Pharmaceuticals, Inc. | 1 | $131 |
| Abiomed | 1 | $126 |
| Incyte Corporation | 1 | $125 |
| Kyowa Kirin, Inc. | 1 | $123 |
| Novo Nordisk | 1 | $122 |
| Johnson & Johnson | 1 | $120 |
| Myovant Sciences Inc. | 1 | $116 |
| Ultragenyx Pharmaceutical Inc. | 1 | $106 |
| Edwards Lifesciences | 1 | $101 |
| GSK | 1 | $99 |
| Idorsia Pharmaceuticals US Inc | 1 | $96 |
| Mylan Specialty L.p. | 1 | $94 |
| Scynexis, Inc. | 1 | $87 |
| Eisai Inc. | 1 | $84 |
| Biogen | 1 | $69 |
| Coloplast | 2 | $54 |
| Medtronic | 1 | $38 |
| Organon | 1 | $15 |
What the payments were tied to
Products named in the reported payments. Only payments of $100 or more are attributed here — the typical reported payment nationally is a meal worth about $16, and listing those product-by-product would be noise.
How this compares
$9,713 in reported general payments places this provider in the 95th percentile of 15,456 family providers in Texas.
Other family in Houston
- Robin BeachHouston$428K
- Sarah AguilarHouston$199K
- Margaret WhiteHouston$85K
- Cheryl HaseebHouston$42K
- Kendrick ClackHouston$28K
- David WeirDallas$959K
- April LopezMcAllen$417K
- Sie ThomasDallas$197K
- Anna CastroSan Antonio$184K
- Jill CampbellShenandoah$182K
Where these figures come from
- Payments: CMS Open Payments, program years 2019–2025 (publication P06302026_06032026).
- Identity: NPPES NPI Registry, July 2026.